Archived Facts

BOSTON (Reuters) – The drug-mixing company at the heart of a deadly U.S. meningitis outbreak solicited bulk orders from physicians and failed to require proof of individual patient prescriptions as required under state regulations, emails to a customer show.

Popular Posts:

Related Posts:

  • No Related Posts

Leave a Reply